+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 40Years +
FEMALE
ID06867484

Study of Breast Cancer Re-irradiation After Second Lumpectomy Using Intensity Modulated Radiation Therapy IMRT For ER HER2-negative Patients Aged 40 and Older

Led by Youssef Zeidan · Updated on 2025-11-13

114

Participants Needed

2

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and possible harms of reirradiation treatment for breast cancer patients who have already received radiation before surgery. This study focuses on women diagnosed with estrogen receptor-positive and HER2-negative breast cancer who have had a second ipsilateral lumpectomy. The goal is to learn about both the beneficial and adverse effects of this reirradiation approach. Participants will receive intensity modulated radiation therapy IMRT, delivered as 40 Gy total dose in 15 consecutive weekday sessions targeting the partial breast. Prior radiation treatments including brachytherapy, external beam MV photons, protons, or intraoperative radiation are allowed within dose limits. The study requires a minimum interval of 18 months since the last breast radiotherapy. During the study, researchers will monitor treatment-related adverse events for one year and assess long-term outcomes such as local recurrence-free survival, overall survival, distant metastasis-free survival, mastectomy-free survival, and patient-rated cosmetic changes over five years. Participants will undergo regular evaluations and follow-up to track these outcomes, with the total participation duration spanning multiple years.

CONDITIONS

Brief Title

Breast Re-irradiation After Second Ipsilateral Lumpectomy

Research Team

Y

Youssef Zeidan, M.D., Ph.D.

M

MCI Multisite Research Program

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here